United States Patent 6,126,646 (Adaptor Top for Making Standard Cartridges Fit Syringes): Claim Evaluation and US Patent Landscape
US Patent 6,126,646 centers on a plastic adaptor top that converts a “standard cartridge” (neck flange sealed by a rubber membrane and a metal cover with an edge beaded behind the flange) into a configuration that can be retained and oriented inside a syringe, using (i) an axially bored plastic interface with radially inwardly gripping protrusions that lock behind the metal beaded edge and (ii) optional syringe-retention and needle-attachment features such as an outer thread and anti-rotation interlocks. A dependent claim adds a color-coding scheme for insulin type identification.
This analysis is organized as a claim-by-claim validity and enforcement assessment, followed by a landscape view of likely relevant US patent families and design-arounds.
What does the independent claim require in practice? (Claim 1)
Core limitation set (Claim 1)
Claim 1 requires all of the following structural and functional elements:
-
Cartridge type and metal sealing architecture
- “standard cartridge” having:
- a neck part with a flange
- closed by a rubber membrane sealingly secured against the flange
- a metal cover whose edge is beaded behind the flange.
-
Plastic adaptor top with a bore matching the metal cover
- An axially extending bore (2) with diameter conforming to the diameter of the metal cover.
-
Plastic deformation to create a mechanical lock
- The adaptor top is plastic and may be deformed so that at least one radially inwardly extending protrusion can be pressed outward when the cartridge neck is inserted into the bore.
- After insertion, the protrusion must be positioned axially within the bore to grip behind the beaded edge after the metal cover is pressed into the bore.
- Result: the adaptor top is secured to the metal cover.
-
Syringe compatibility via an exterior contour
- The adaptor top has an outer contour that can be received into and engage an interior portion of a syringe.
- Result: the standard cartridge becomes usable in a syringe where it otherwise would not fit.
Claim 1 is tightly framed to the beaded-edge grip geometry
The most consequential novelty hook in Claim 1 is not “an adaptor” in general, but a specific mechanical retention scheme:
- a bore sized to the metal cover, and
- in-bore protrusions that grip behind the beaded edge of the metal cover once insertion occurs.
That creates a relatively narrow claim envelope: it maps to cartridges with a metal cover that has a beaded edge behind the flange, and to adaptors that retain by that reverse-bead lock rather than friction-only, adhesive, snap-only, or sleeve-only approaches.
How does claim scope shift in the thread-dependent claims? (Claims 2 and 3)
Claim 2: What does it add?
Claim 2 adds a single additional limitation:
- a thread coaxial with the bore, provided as an outer thread on the outer contour.
Effect on scope
- Claim 2 is still centered on the same insertion-and-grip retention mechanism as Claim 1.
- The thread requirement makes the adaptor top compatible with threaded components (e.g., needle hub mounting) and reduces the set of potential infringers.
Claim 3: What does it expand and what does it narrow?
Claim 3 re-states Claim 1 elements and adds multiple constraints:
- The outer contour must include interlocking means to prevent rotation in the syringe.
- The adaptor top has a thread coaxial with the bore “to receive a threaded needle hub.”
Scope effects
- Narrowing: Interlocking means with corresponding syringe means is a functional claim component, but it still requires some anti-rotation interaction rather than pure press-fit retention.
- Narrowing: It requires a thread sized/positioned for a threaded needle hub, not just any external contour.
Key practical point
- Claim 3 is likely to read on adaptors designed for two interfaces simultaneously:
- cartridge-to-adaptor retention (beaded edge grip), and
- adaptor-to-syringe retention (anti-rotation interlock) plus
- adaptor-to-needle attachment (thread for needle hub).
That combination is harder to achieve with generic “universal cartridge adapters,” which often focus only on cartridge retention.
How specific are the anti-rotation features? (Claim 4)
Claim 4 narrows Claim 3 by specifying the anti-rotation interlocking means as:
- “knobs (7) at the lower end of the top,”
- knobs have triangular cross-sections with an apex directed upwardly.
Enforcement impact
- This is a structural limitation that can be compared directly against accused designs.
- If a competitor uses:
- splines,
- flats,
- lugs of different cross-section,
- radial ribs with different geometry,
- or a different anti-rotation mechanism,
then Claim 4 may not be met even if Claim 3 is met.
What does the insulin color-coding claim add? (Claim 5)
Claim 5 is dependent on Claim 1 and covers:
- use with a standard insulin cartridge that contains different types of insulin,
- where the adaptor top is colored per a color code system,
- each color indicates insulin type.
Legal/portfolio impact
- If the color code is determined by an external convention or labeling practice, this claim can be vulnerable to obviousness arguments based on existing insulin labeling and user-interface practices.
- From a design-around perspective, color-coding does not change the mechanical cartridge-grip feature, so competitors can potentially avoid Claim 5 without materially affecting the core adapter structure.
What is the risk profile for validity challenges? (Critical claim vulnerability mapping)
1) Claim 1’s novelty depends on the beaded-edge grip + deformation
If the prior art shows adaptor tops that grip behind the beaded metal edge of a standard cartridge using radially inward protrusions and a plastic deformable bore, Claim 1 becomes at risk for anticipation or obviousness.
Critical test
- Does prior art disclose all elements:
- standard cartridge structure with beaded metal cover edge behind flange,
- adaptor with bore matching metal cover diameter,
- inward protrusions positioned axially inside bore,
- plastic deformation permitting protrusion snap-in behind beaded edge,
- exterior contour that engages syringe interior so the cartridge fits.
Even one missing element typically defeats anticipation, but obviousness can still be argued if multiple references each supply most elements and the motivation to combine is present.
2) Claims 2 and 3 are vulnerable if threaded needle hubs and anti-rotation features were conventional
Threaded interfaces for needle hubs are well understood in syringe/needle systems. Anti-rotation features and locking geometries are also common in fittings and adapters.
The defensible point in Claims 2-3 is the combination with the specific cartridge retention mechanism from Claim 1.
3) Claim 4’s triangular-knob geometry is likely to be the easiest to design around
Geometry-specific limitations reduce infringement reach. Competitors can shift knob profile or use different interlock features.
4) Claim 5 (color coding) is the most easily challenged on obviousness
If prior art exists for color-coded insulin cartridges or insulin administration adapters, then Claim 5 may be an incremental UI feature layered onto a known mechanical adapter.
How would competitors design around this patent? (Landscape-driven design paths)
Design-around axis A: cartridge retention mechanism
To avoid Claim 1, a competitor can change the cartridge-adaptor coupling such that it does not:
- use a bore sized to the metal cover diameter, and
- grip behind the beaded edge with axially positioned protrusions.
Alternative strategies:
- use a sleeve that clamps around the neck flange rather than engaging the beaded edge,
- use solvent bonding or ultrasonic welding,
- use pure friction-only retention without a behind-the-bead lock,
- use a different internal feature such as circumferential O-ring compression rather than protrusion capture behind a beaded edge.
This strategy is the most decisive because it attacks the core “grip behind beaded edge” architecture.
Design-around axis B: syringe engagement geometry
Claims 1 and 3 require an outer contour received in and engaged with syringe interior portion. Claim 3 further requires interlocking means to prevent rotation.
A design that uses:
- only a friction fit without anti-rotation interlock,
or
- an anti-rotation mechanism that does not correspond to the claimed “interlocking means” requirement
reduces risk for Claim 3 but may still implicate Claim 1 if the “outer contour suitable to be received and engage” is still met.
Design-around axis C: needle hub attachment
If a competitor avoids an outer thread coaxial with the bore intended for a threaded needle hub, then Claim 2 and Claim 3 become harder to satisfy.
Design-around axis D: anti-rotation knob geometry
To avoid Claim 4, switch from triangular-knob apex-up shapes to:
- different knob cross-sections,
- lugs placed at different axial positions,
- spiral ribs,
- a bayonet-style twist-lock,
- or a spline/flat interface.
Design-around axis E: insulin color coding
Avoid Claim 5 by:
- not using color coding,
- using monochrome,
- encoding insulin type by text/label rather than color on the adaptor top,
- or applying color scheme that differs from the claimed color code system (if the claim is construed narrowly around the specific color code).
US patent landscape: what likely sits around this claim space?
A full claim-chart-level landscape requires the exact publication record, the issuing file history, and the closest prior art references cited during prosecution. Those are not provided in the prompt. Under a strict “actionable business” lens, the relevant landscape categories for this type of adapter are clear, and they tend to show up across multiple US filings:
- Syringe adapters for cartridges
- US patents that convert nonstandard cartridges into syringe-compatible holders using snap-fit or bayonet retention.
- Cartridge-to-adaptor retention mechanisms
- Publications describing internal ribs, protrusions, and annular catches that engage around cartridge necks, flanges, or metal caps.
- Needle hub interfaces
- Patents that use threaded hubs coaxial with needle cannula attachment, including anti-rotation.
- Insulin cartridge identification interfaces
- Patents that color-code or otherwise identify insulin type, often tied to user safety and medication management systems.
- Standard cartridge mechanical construction
- Patents describing cartridges with a metal cover and beaded edge or equivalent locking profile.
Critical business takeaway for the landscape
If the strongest prior art exists, it will likely be in the combination space:
- a syringe adapter that already uses a cartridge retention “catch behind a bead/collar,” plus
- a syringe interface that prevents rotation, plus
- an external thread for needle hub.
Even if any single reference lacks the full combination, obviousness exposure rises rapidly if multiple references provide the missing pieces and the motivation to combine is straightforward (universal compatibility, user safety, and needle attachment standardization).
Enforcement outlook: which claims carry the most leverage?
-
Claim 1 (core mechanical retention)
- Highest leverage if the beaded-edge grip feature is not common in prior art.
- It is also the hardest to design around without changing the core retention architecture.
-
Claim 2 and Claim 3 (thread + syringe anti-rotation + needle hub compatibility)
- Leverage improves if competitor designs include the thread and anti-rotation features.
- Risk remains if thread/anti-rotation elements are conventional.
-
Claim 4 (triangular knobs)
- Likely moderate leverage; strongest when accused device matches that geometry.
-
Claim 5 (color coding)
- Narrow leverage; most vulnerable on obviousness and easiest to avoid through non-color encoding.
Key Takeaways
- The patent’s enforceable core is Claim 1’s mechanical retention: a plastic bore sized to the metal cover plus axially positioned radially inward protrusions that grip behind the beaded edge of the metal cover after insertion.
- Claims 2 and 3 layer conventional syringe/needle interface concepts (threads, anti-rotation) onto that specific retention scheme, making them more likely to be infringed only if a competitor matches the full multi-interface design.
- Claim 4’s triangular-knob geometry is a strong design-around lever because it narrows anti-rotation structure.
- Claim 5 (color coding) is the most vulnerable and easiest to avoid; it depends on whether prior art already teaches medication-type identification by color on insulin administration components.
- Landscape risk is highest in references that combine cartridge-adaptor snap or catch retention with syringe compatibility and needle hub threading.
FAQs
1) What is the single most important element to prove infringement of the independent claim?
The adaptor must have an axially extending bore sized to the metal cover and must use radially inwardly extending protrusions positioned axially to grip behind the metal cover’s beaded edge after insertion.
2) Does a competitor need to match the syringe outer contour exactly?
Not necessarily exactly, but the adaptor outer contour must be suitable to be received in and engage an interior portion of the syringe to retain the cartridge where it otherwise would not fit.
3) How do Claims 2 and 3 differ from Claim 1 in infringement analysis?
They add a coaxial external thread (Claim 2) and, for Claim 3, both anti-rotation interlocking features for the syringe and thread compatibility for a threaded needle hub.
4) Which claim is easiest to avoid by changing geometry?
Claim 4, because it specifies triangular cross-section knobs with the apex directed upwardly.
5) Which claim is most likely to be vulnerable on “obviousness” grounds?
Claim 5, because it is a color-coding UI layer tied to insulin type identification, which commonly appears in existing medication labeling and administration user-interface practice.
References
[1] US Patent 6,126,646.
